Maravai LifeSciences Holdings, Inc. MRVI Products & Services — Cost of revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s products & services — cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s products & services — cost of revenue?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported products & services — cost of revenue of $1.08M in Q4 2025.
- How has Maravai LifeSciences Holdings, Inc.'s products & services — cost of revenue changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s products & services — cost of revenue increased by 4.9% year-over-year, from $1.03M to $1.08M.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s products & services — cost of revenue?
- Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s products & services — cost of revenue has grown at a 4.5% compound annual growth rate (CAGR), from $3.6M to $4.3M.
- What does products & services — cost of revenue mean?
- This metric represents the direct costs incurred by the company to transport and deliver products to customers within the specific shipping and handling business segment. It encompasses expenses related to freight, logistics, packaging, and distribution activities necessary to fulfill customer orders. Monitoring this cost helps assess the operational efficiency of the supply chain and the impact of logistics pricing on the segment's overall gross margin.